85 related articles for article (PubMed ID: 22186784)
41. Myb controls intestinal stem cell genes and self-renewal.
Cheasley D; Pereira L; Lightowler S; Vincan E; Malaterre J; Ramsay RG
Stem Cells; 2011 Dec; 29(12):2042-50. PubMed ID: 21997934
[TBL] [Abstract][Full Text] [Related]
42. c-MYB regulates cell growth and DNA damage repair through modulating MiR-143.
Wang W; Wu S; Shi Y; Miao Y; Luo X; Ji M; Yao K; He J
FEBS Lett; 2015 Feb; 589(5):555-64. PubMed ID: 25616133
[TBL] [Abstract][Full Text] [Related]
43. [Progress of research on Proto-oncogene c-myc, c-myb in platelet diseases].
Zhang Y; Chen R; Zhao L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):274-8. PubMed ID: 21362267
[TBL] [Abstract][Full Text] [Related]
44. TGFβ Induces a Pro-Bone Metastasis Program in Prostate Cancer.
Cancer Discov; 2015 Jul; 5(7):OF23. PubMed ID: 26022606
[TBL] [Abstract][Full Text] [Related]
45. Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells.
Wang J; Yang L; Yang J; Kuropatwinski K; Wang W; Liu XQ; Hauser J; Brattain MG
Cancer Res; 2008 May; 68(9):3152-60. PubMed ID: 18451140
[TBL] [Abstract][Full Text] [Related]
46. Myb proteins inhibit fibroblast transformation by v-Rel.
Fu SL; Ganter B; Lipsick JS
Mol Cancer; 2006 Nov; 5():54. PubMed ID: 17081304
[TBL] [Abstract][Full Text] [Related]
47. TGFβ regulates NK1R-Tr to affect the proliferation and apoptosis of breast cancer cells.
Wang L; Wang N; Zhang R; Dong D; Liu R; Zhang L; Ji W; Yu M; Zhang F; Niu R; Zhou Y
Life Sci; 2020 Sep; 256():117674. PubMed ID: 32380077
[TBL] [Abstract][Full Text] [Related]
48. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb.
Zhang J; Luo N; Luo Y; Peng Z; Zhang T; Li S
Int J Oncol; 2012 Mar; 40(3):747-56. PubMed ID: 22025269
[TBL] [Abstract][Full Text] [Related]
49. c-Myb Regulates Proliferation and Differentiation of Adventitial Sca1+ Vascular Smooth Muscle Cell Progenitors by Transactivation of Myocardin.
Shikatani EA; Chandy M; Besla R; Li CC; Momen A; El-Mounayri O; Robbins CS; Husain M
Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1367-76. PubMed ID: 27174098
[TBL] [Abstract][Full Text] [Related]
50. c-myb stimulates cell growth by regulation of insulin-like growth factor (IGF) and IGF-binding protein-3 in K562 leukemia cells.
Kim MS; Kim SY; Arunachalam S; Hwang PH; Yi HK; Nam SY; Lee DY
Biochem Biophys Res Commun; 2009 Jul; 385(1):38-43. PubMed ID: 19427836
[TBL] [Abstract][Full Text] [Related]
51. Presence of circulating anti-c-myb oncogene product antibodies in human sera.
Sorokine I; Ben-Mahrez K; Bracone A; Thierry D; Ishii S; Imamoto F; Kohiyama M
Int J Cancer; 1991 Mar; 47(5):665-9. PubMed ID: 2004847
[TBL] [Abstract][Full Text] [Related]
52. TGF-beta gene expression depends on tissue architecture.
Theodorescu D; Sheehan C; Kerbel RS
In Vitro Cell Dev Biol; 1993 Feb; 29A(2):105-8. PubMed ID: 8473265
[No Abstract] [Full Text] [Related]
53. Inhibition of Myb-dependent gene expression by the sesquiterpene lactone mexicanin-I.
Bujnicki T; Wilczek C; Schomburg C; Feldmann F; Schlenke P; Müller-Tidow C; Schmidt TJ; Klempnauer KH
Leukemia; 2012 Apr; 26(4):615-22. PubMed ID: 21986841
[TBL] [Abstract][Full Text] [Related]
54. Direct regulation of HSP60 expression by c-MYC induces transformation.
Tsai YP; Teng SC; Wu KJ
FEBS Lett; 2008 Dec; 582(29):4083-8. PubMed ID: 19022255
[TBL] [Abstract][Full Text] [Related]
55. Ribosomal protein L4 positively regulates activity of a c-myb proto-oncogene product.
Egoh A; Nosuke Kanesashi S; Kanei-Ishii C; Nomura T; Ishii S
Genes Cells; 2010 Aug; 15(8):829-41. PubMed ID: 20604807
[TBL] [Abstract][Full Text] [Related]
56. ABCG2 expression and side population abundance regulated by a transforming growth factor beta-directed epithelial-mesenchymal transition.
Yin L; Castagnino P; Assoian RK
Cancer Res; 2008 Feb; 68(3):800-7. PubMed ID: 18245481
[TBL] [Abstract][Full Text] [Related]
57. Plasma transforming growth factor beta levels in breast cancer patients.
Sminia P; Barten AD; van Waarde MA; Vujaskovic Z; van Tienhoven G
Oncol Rep; 1998; 5(2):485-8. PubMed ID: 9468585
[TBL] [Abstract][Full Text] [Related]
58. Intestinal-specific activatable Myb initiates colon tumorigenesis in mice.
Malaterre J; Pereira L; Putoczki T; Millen R; Paquet-Fifield S; Germann M; Liu J; Cheasley D; Sampurno S; Stacker SA; Achen MG; Ward RL; Waring P; Mantamadiotis T; Ernst M; Ramsay RG
Oncogene; 2016 May; 35(19):2475-84. PubMed ID: 26300002
[TBL] [Abstract][Full Text] [Related]
59. MAGI1 mediates tumor metastasis through c-Myb/miR-520h/MAGI1 signaling pathway in renal cell carcinoma.
Wang W; Yang Y; Chen X; Shao S; Hu S; Zhang T
Apoptosis; 2019 Dec; 24(11-12):837-848. PubMed ID: 31352641
[TBL] [Abstract][Full Text] [Related]
60. MYB-QKI drives childhood brain tumors via tripartite mechanism.
Jain P; Resnick AC
Cell Cycle; 2017 Mar; 16(5):390-391. PubMed ID: 27973981
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
